{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:54:05Z","timestamp":1766138045664,"version":"3.44.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000308","name":"Carnegie Corporation of New York","doi-asserted-by":"publisher","award":["b8749"],"award-info":[{"award-number":["b8749"]}],"id":[{"id":"10.13039\/100000308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["121943"],"award-info":[{"award-number":["121943"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.thromres.2022.07.001","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T22:59:51Z","timestamp":1657148391000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Evaluation of markers of fibrinolysis and coagulation in pregnant women with human immunodeficiency virus"],"prefix":"10.1016","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1534-2930","authenticated-orcid":false,"given":"Elise","family":"Schapkaitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Libhaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry F.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marketa","family":"Toman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry R.","family":"B\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.thromres.2022.07.001_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199555","article-title":"Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy","volume":"13","author":"Stringer","year":"2018","journal-title":"PLoS One."},{"issue":"1","key":"10.1016\/j.thromres.2022.07.001_bb0010","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2352-3018(16)30195-3","article-title":"Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis","volume":"4","author":"Uthman","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.thromres.2022.07.001_bb0015","article-title":"Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy","author":"Theron","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.thromres.2022.07.001_bb0020","article-title":"Incidence of a first venous thrombotic event in people with HIV in the Netherlands: a retrospective cohort study","volume":"6","author":"JFB","year":"2019","journal-title":"Lancet HIV"},{"key":"10.1016\/j.thromres.2022.07.001_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/ijgo.13596","article-title":"Pregnancy-related venous thromboembolism and HIV infection","author":"Schapkaitz","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"3","key":"10.1016\/j.thromres.2022.07.001_bb0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/infdis\/jiv416","article-title":"Inflammatory markers related to microbial translocation among HIV-infected pregnant women: a risk factor of preterm delivery","volume":"213","author":"Lopez","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.thromres.2022.07.001_bb0035","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/cid\/ciy253","article-title":"Intestinal barrier dysfunction and microbial translocation in human immunodeficiency virus-infected pregnant women are associated with preterm birth","volume":"67","author":"Shivakoti","year":"2018","journal-title":"Clin Infect Dis."},{"issue":"10","key":"10.1016\/j.thromres.2022.07.001_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.thromres.2022.07.001_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024243","article-title":"Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a south african cohort with advanced HIV disease","volume":"7","author":"Ledwaba","year":"2012","journal-title":"PLoS One."},{"issue":"6","key":"10.1016\/j.thromres.2022.07.001_bb0050","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/QAD.0b013e3283453fcb","article-title":"Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV","volume":"25","author":"Musselwhite","year":"2011","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.thromres.2022.07.001_bb0055","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"13","key":"10.1016\/j.thromres.2022.07.001_bb0060","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1097\/QAD.0000000000002305","article-title":"Inflammatory biomarkers prior to antiretroviral therapy as prognostic markers of 12-month mortality in South Africa and Uganda","volume":"33","author":"Siedner","year":"2019","journal-title":"Aids"},{"key":"10.1016\/j.thromres.2022.07.001_bb0065","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fmicb.2015.00180","article-title":"von Willebrand Factor is elevated in HIV patients with a history of thrombosis.","volume":"6","author":"van den Dries","year":"2015","journal-title":"Front Microbiol."},{"issue":"5","key":"10.1016\/j.thromres.2022.07.001_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155100","article-title":"Relevance of Interleukin-6 and D-dimer for serious non-AIDS morbidity and death among HIV-positive adults on suppressive antiretroviral therapy","volume":"11","author":"Grund","year":"2016","journal-title":"PLoS One."},{"issue":"3","key":"10.1016\/j.thromres.2022.07.001_bb0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/QAI.0000000000000306","article-title":"Association of markers of hemostasis with death in HIV-infected women","volume":"67","author":"Kiefer","year":"2014","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"11","key":"10.1016\/j.thromres.2022.07.001_bb0080","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/QAD.0000000000000675","article-title":"The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels","volume":"29","author":"Hamlyn","year":"2015","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.thromres.2022.07.001_bb0085","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12879-020-05213-1","article-title":"Changes in D-dimer after initiation of antiretroviral therapy in adults living with HIV in Kenya","volume":"20","author":"Teasdale","year":"2020","journal-title":"BMC Infect Dis."},{"issue":"10","key":"10.1016\/j.thromres.2022.07.001_bb0090","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/hiv.12665","article-title":"Longitudinal evaluation of markers of inflammation in HIV-positive and HIV-negative Rwandan women","volume":"19","author":"Kiefer","year":"2018","journal-title":"HIV Med."},{"issue":"5","key":"10.1016\/j.thromres.2022.07.001_bb0095","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/QAI.0000000000001629","article-title":"Brief report: higher ART adherence is associated with lower systemic inflammation in treatment-naive Ugandans who achieve virologic suppression","volume":"77","author":"Castillo-Mancilla","year":"2018","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"4","key":"10.1016\/j.thromres.2022.07.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214735","article-title":"Inflammatory biomarkers and subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study","volume":"14","author":"Subramanya","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.thromres.2022.07.001_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152588","article-title":"D-dimer levels before HIV seroconversion remain elevated even after viral suppression and are associated with an increased risk of non-AIDS events","volume":"11","author":"Freiberg","year":"2016","journal-title":"PLoS One."},{"issue":"4","key":"10.1016\/j.thromres.2022.07.001_bb0110","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx262","article-title":"Systemic inflammation, coagulation, and clinical risk in the START trial","volume":"4","author":"Baker","year":"2017","journal-title":"Open Forum Infect Dis."},{"issue":"8","key":"10.1016\/j.thromres.2022.07.001_bb0115","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/MBC.0b013e3282f1012d","article-title":"Effect of antiretroviral therapy on hemostasis in Brazilian pregnant women with HIV infection","volume":"18","author":"de Andrade","year":"2007","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"1\u20132","key":"10.1016\/j.thromres.2022.07.001_bb0120","first-page":"39","article-title":"Markers of endothelial activation in preeclampsia","volume":"61","author":"Prochazka","year":"2015","journal-title":"Clin. Lab."},{"issue":"2","key":"10.1016\/j.thromres.2022.07.001_bb0125","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MBC.0000000000000675","article-title":"Thrombin potential and traditional coagulation assay: are they useful in exploring recurrent pregnancy loss risk?","volume":"29","author":"Romagnuolo","year":"2018","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"12","key":"10.1016\/j.thromres.2022.07.001_bb0130","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1111\/jth.15502","article-title":"von Willebrand factor propeptide-to-antigen ratio in HIV-infected pregnancy: Evidence of endothelial activation","volume":"19","author":"Schapkaitz","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2022.07.001_bb0135","first-page":"273","article-title":"Plasma D-dimer reference ranges in pregnant nigerians","volume":"43","author":"Osunkalu","year":"2014","journal-title":"Afr. J. Med. Med. Sci."},{"key":"10.1016\/j.thromres.2022.07.001_bb0140","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2012.05.027","article-title":"Tissue factor-dependent thrombin generation across pregnancy","volume":"207","author":"McLean","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.thromres.2022.07.001_bb0145","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.thromres.2012.03.026","article-title":"Characterization of negatively charged phospholipids and cell origin of microparticles in women with gestational vascular complications","volume":"130","author":"Katzenell","year":"2012","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2022.07.001_bb0150","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/bjh.15102","article-title":"The DiPEP (Diagnosis of PE in Pregnancy) biomarker study: An observational cohort study augmented with additional cases to determine the diagnostic utility of biomarkers for suspected venous thromboembolism during pregnancy and puerperium","volume":"180","author":"Hunt","year":"2018","journal-title":"British journal of haematology"},{"issue":"4","key":"10.1016\/j.thromres.2022.07.001_bb0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/molehr\/gah031","article-title":"Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9","volume":"10","author":"Anteby","year":"2004","journal-title":"Mol Hum Reprod."},{"key":"10.1016\/j.thromres.2022.07.001_bb0160","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7124186","article-title":"Increased Umbilical Cord PAI-1 Levels in Placental Insufficiency Are Associated with Fetal Hypoxia and Angiogenesis","volume":"2016","author":"Seferovic","year":"2016","journal-title":"Dis Markers"},{"issue":"6","key":"10.1016\/j.thromres.2022.07.001_bb0165","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1538-7836.2009.03344.x","article-title":"Pregnancy outcome and fibrinolytic, endothelial and coagulation markers in women undergoing uterine artery Doppler screening at 23 weeks","volume":"7","author":"Hunt","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2022.07.001_bb0170","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-0038-1650330","article-title":"The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group","volume":"75","author":"Schulman","year":"1996","journal-title":"Thromb Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2022.07.001_bb0175","first-page":"1228","article-title":"The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in south african HIV-infected individuals","volume":"104","author":"Jong","year":"2010","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2022.07.001_bb0180","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/01.qai.0000230320.78288.79","article-title":"Progressive prothrombotic state in women with advancing HIV disease","volume":"42","author":"Levine","year":"2006","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"3","key":"10.1016\/j.thromres.2022.07.001_bb0185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/QAI.0b013e31827fdd61","article-title":"Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS).","volume":"62","author":"Kiefer","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"5","key":"10.1016\/j.thromres.2022.07.001_bb0190","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1538-7836.2011.04242.x","article-title":"Persistently raised plasma levels of platelet-derived inflammatory mediators in HIV-infected patients during highly active anti-retroviral therapy","volume":"9","author":"Landro","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.07.001_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-6405-7-9","article-title":"Markers of inflammation and coagulation indicate a prothrombotic state in HIV-infected patients with long-term use of antiretroviral therapy with or without abacavir","volume":"7","author":"Jong","year":"2010","journal-title":"AIDS Res Ther."},{"key":"10.1016\/j.thromres.2022.07.001_bb0200","article-title":"Prevalence of hypertensive disorders of pregnancy and pregnancy outcomes in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"16","author":"Gemechu","year":"2020","journal-title":"Womens Health (Lond)"},{"issue":"11","key":"10.1016\/j.thromres.2022.07.001_bb0205","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/infdis\/jis553","article-title":"Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana","volume":"206","author":"Chen","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.thromres.2022.07.001_bb0210","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.thromres.2022.07.001_bb0215","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1086\/655229","article-title":"Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy","volume":"202","author":"Cassol","year":"2010","journal-title":"J Infect Dis."},{"issue":"1","key":"10.1016\/j.thromres.2022.07.001_bb0220","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.tim.2012.09.001","article-title":"Microbial translocation, immune activation, and HIV disease","volume":"21","author":"Klatt","year":"2013","journal-title":"Trends Microbiol."},{"issue":"2","key":"10.1016\/j.thromres.2022.07.001_bb0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2009-03-210179","article-title":"Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation","volume":"115","author":"Funderburg","year":"2010","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.thromres.2022.07.001_bb0230","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1511691","article-title":"Benefits and risks of antiretroviral therapy for perinatal HIV prevention","volume":"375","author":"Fowler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2022.07.001_bb0235","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0000000000002072","article-title":"Risk factors for adverse birth outcomes in the PROMISE 1077BF\/1077FF trial","author":"Sebikari","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"8","key":"10.1016\/j.thromres.2022.07.001_bb0240","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1080\/14767050902853117","article-title":"Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death","volume":"22","author":"Erez","year":"2009","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"2","key":"10.1016\/j.thromres.2022.07.001_bb0245","first-page":"115","article-title":"Increased Plasma Levels of Platelet Factor 4 and beta-thromboglobulin in Women with Recurrent Pregnancy Loss","volume":"74","author":"Kotani","year":"2020","journal-title":"Acta Med. Okayama"},{"issue":"4","key":"10.1016\/j.thromres.2022.07.001_bb0250","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/QAI.0b013e3182439355","article-title":"Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression","volume":"59","author":"Mayne","year":"2012","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"1","key":"10.1016\/j.thromres.2022.07.001_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33403-0","article-title":"Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals","volume":"8","author":"Mesquita","year":"2018","journal-title":"Sci Rep."},{"issue":"6","key":"10.1016\/j.thromres.2022.07.001_bb0260","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.thromres.2015.01.031","article-title":"The evaluation of platelet function in HIV infected, asymptomatic treatment-naive individuals using flow cytometry","volume":"135","author":"Nkambule","year":"2015","journal-title":"Thromb Res."},{"issue":"2","key":"10.1016\/j.thromres.2022.07.001_bb0265","first-page":"349","article-title":"In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients","volume":"110","author":"Falcinelli","year":"2013","journal-title":"Thromb Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2022.07.001_bb0270","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/infdis\/jir509","article-title":"Increased platelet reactivity in HIV-1-infected patients receiving abacavir-containing antiretroviral therapy","volume":"204","author":"Satchell","year":"2011","journal-title":"J Infect Dis."},{"issue":"5","key":"10.1016\/j.thromres.2022.07.001_bb0275","first-page":"343","article-title":"Platelet aggregation and serum adenosine deaminase (ADA) activity in pregnancy associated with diabetes, hypertension and HIV","volume":"34","author":"Leal","year":"2016"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822003085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822003085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:48:45Z","timestamp":1758736125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384822003085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":55,"alternative-id":["S0049384822003085"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2022.07.001","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of markers of fibrinolysis and coagulation in pregnant women with human immunodeficiency virus","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2022.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}